Published in Lancet on November 30, 2002
Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging (2005) 3.32
Innate immunity and inflammation in ageing: a key for understanding age-related diseases. Immun Ageing (2005) 1.99
Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers. Neurology (2006) 1.89
Measures of adiposity and dementia risk in elderly persons. Arch Neurol (2007) 1.88
Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease: an epidemiological perspective. Eur J Pharmacol (2008) 1.82
Stroke and memory performance in elderly persons without dementia. Arch Neurol (2006) 1.65
Body mass index over the adult life course and cognition in late midlife: the Whitehall II Cohort Study. Am J Clin Nutr (2008) 1.65
Adiposity, type 2 diabetes, and Alzheimer's disease. J Alzheimers Dis (2009) 1.53
Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City Study. Diabetes Care (2008) 1.52
Successful aging: the contribution of early-life and midlife risk factors. J Am Geriatr Soc (2008) 1.48
Postoperative adverse outcomes in surgical patients with dementia: a retrospective cohort study. World J Surg (2012) 1.48
Competitive Mirror Image Phage Display Derived Peptide Modulates Amyloid Beta Aggregation and Toxicity. PLoS One (2016) 1.40
Health behaviors from early to late midlife as predictors of cognitive function: The Whitehall II study. Am J Epidemiol (2009) 1.30
Type 2 diabetes and cognitive impairment: linking mechanisms. J Alzheimers Dis (2012) 1.28
Effect of smoking and time on cognitive function in the elderly without dementia. Neurology (2005) 1.19
History of coronary heart disease and cognitive performance in midlife: the Whitehall II study. Eur Heart J (2008) 1.17
Prediction of Alzheimer's disease in subjects with mild cognitive impairment from the ADNI cohort using patterns of cortical thinning. Neuroimage (2012) 1.17
Adiposity and Alzheimer's disease. Curr Opin Clin Nutr Metab Care (2009) 1.17
Personality and risk for Alzheimer's disease in adults 72 years of age and older: a 6-year follow-up. Psychol Aging (2011) 1.14
The effects of cardiovascular risk factors on cognitive compromise. Dialogues Clin Neurosci (2009) 1.13
Statins, risk of dementia, and cognitive function: secondary analysis of the ginkgo evaluation of memory study. J Stroke Cerebrovasc Dis (2011) 1.12
Maternal transmission of Alzheimer's disease: prodromal metabolic phenotype and the search for genes. Hum Genomics (2010) 1.12
How a neuropsychiatric brain bank should be run: a consensus paper of Brainnet Europe II. J Neural Transm (Vienna) (2006) 1.07
Persistent depressive symptoms and cognitive function in late midlife: the Whitehall II study. J Clin Psychiatry (2010) 1.05
Cognitive impairment in heart failure. Cardiol Res Pract (2012) 1.03
Sulforaphane as a potential protective phytochemical against neurodegenerative diseases. Oxid Med Cell Longev (2013) 1.03
Traditional chinese medicine for senile dementia. Evid Based Complement Alternat Med (2011) 1.02
Delphi research exploring essential components and preconditions for case management in people with dementia. BMC Geriatr (2010) 1.01
β-arrestin1 regulates γ-secretase complex assembly and modulates amyloid-β pathology. Cell Res (2012) 0.95
Vascular aspects of cognitive impairment and dementia. J Cereb Blood Flow Metab (2013) 0.95
Reduction of amyloid angiopathy and Abeta plaque burden after enriched housing in TgCRND8 mice: involvement of multiple pathways. Am J Pathol (2006) 0.94
Central obesity in the elderly is related to late-onset Alzheimer disease. Alzheimer Dis Assoc Disord (2012) 0.94
Visual assessment of [(11)C]PIB PET in patients with cognitive impairment. Eur J Nucl Med Mol Imaging (2010) 0.93
Relation between vascular risk factors and neuropsychological test performance among elderly persons with Alzheimer's disease. J Neurol Sci (2007) 0.92
Adiposity and Alzheimer's disease. Curr Alzheimer Res (2007) 0.92
Structural neuroimaging of social cognition in progressive non-fluent aphasia and behavioral variant of frontotemporal dementia. Front Hum Neurosci (2013) 0.91
Heart disease as a risk factor for dementia. Clin Epidemiol (2013) 0.89
Prediction of Alzheimer dementia with short neuropsychological instruments. J Neural Transm (Vienna) (2009) 0.87
Wine polyphenols: potential agents in neuroprotection. Oxid Med Cell Longev (2012) 0.87
The importance of cognitive aging for understanding dementia. Age (Dordr) (2010) 0.86
Antioxidant nutrients and age-related cognitive decline: a systematic review of population-based cohort studies. Eur J Nutr (2013) 0.84
Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG). Nutr J (2016) 0.81
Is brain banking of psychiatric cases valuable for neurobiological research? Clinics (Sao Paulo) (2008) 0.81
Normal pressure hydrocephalus or neuroborreliosis? Wien Med Wochenschr (2009) 0.81
Classification of the dementias. Lancet (2003) 0.81
Effectiveness of balance training exercise in people with mild to moderate severity Alzheimer's disease: protocol for a randomised trial. BMC Geriatr (2009) 0.79
Cognitive Impairment and Age-Related Vision Disorders: Their Possible Relationship and the Evaluation of the Use of Aspirin and Statins in a 65 Years-and-Over Sardinian Population. Front Aging Neurosci (2014) 0.79
Chronic Toxoplasma gondii infection enhances β-amyloid phagocytosis and clearance by recruited monocytes. Acta Neuropathol Commun (2016) 0.78
Effect of music intervention on the cognitive and depression status of senior apartment residents in Taiwan. Neuropsychiatr Dis Treat (2015) 0.78
Exercise and cognitive function: a hypothesis for the association of type II diabetes mellitus and Alzheimer's disease from an evolutionary perspective. Diabetol Metab Syndr (2009) 0.78
Predicting cognitive function from clinical measures of physical function and health status in older adults. PLoS One (2015) 0.77
Premature centromere division of metaphase chromosomes in peripheral blood lymphocytes of Alzheimer's disease patients: relation to gender and age. J Gerontol A Biol Sci Med Sci (2010) 0.77
Relation of Blood Pressure to Cognitive Impairment and Dementia. Curr Hypertens Rev (2007) 0.77
Association between interleukin-1α C(-889)T polymorphism and Alzheimer's disease: a meta-analysis including 12,817 subjects. J Neural Transm (Vienna) (2012) 0.76
Artificial neural networks allow the use of simultaneous measurements of Alzheimer disease markers for early detection of the disease. J Transl Med (2005) 0.76
Agitation in dementia: relation to core cerebrospinal fluid biomarker levels. Dement Geriatr Cogn Dis Extra (2014) 0.76
End-of Life Issues in the Context of Alzheimer's Disease. Alzheimers Care Q (2003) 0.75
Effects of multiple training modalities in patients with Alzheimer's disease: a pilot study. Neuropsychiatr Dis Treat (2016) 0.75
Multi factorial interactions in the pathogenesis pathway of Alzheimer's disease: a new risk charts for prevention of dementia. Immun Ageing (2010) 0.75
Association of traditional Chinese medicine therapy and the risk of dementia in patients with hypertension: a nationwide population-based cohort study. BMC Complement Altern Med (2017) 0.75
Insulin deprivation induces PP2A inhibition and tau hyperphosphorylation in hTau mice, a model of Alzheimer's disease-like tau pathology. Sci Rep (2017) 0.75
Using the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) for Predicting Institutionalization of Patients With Dementia in Taiwan. Medicine (Baltimore) (2015) 0.75
Regulatory aspects of mild cognitive impairment: toward a harmonized perspective. Dialogues Clin Neurosci (2004) 0.75
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet (2009) 15.15
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
Protective variant for hippocampal atrophy identified by whole exome sequencing. Ann Neurol (2015) 5.10
Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch Neurol (2007) 5.09
Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Arch Gen Psychiatry (2010) 3.64
Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood. Genome Biol (2012) 3.31
The GSK3 hypothesis of Alzheimer's disease. J Neurochem (2007) 3.16
The South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLAM BRC) case register: development and descriptive data. BMC Psychiatry (2009) 3.15
Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants. Hum Mol Genet (2007) 2.73
Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease. PLoS One (2010) 2.57
Is MCI really just early dementia? A systematic review of conversion studies. Int Psychogeriatr (2004) 2.54
A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease. Am J Hum Genet (2005) 2.04
Association of late-onset Alzheimer's disease with genetic variation in multiple members of the GAPD gene family. Proc Natl Acad Sci U S A (2004) 1.95
Alzheimer's disease-do tauists and baptists finally shake hands? Trends Neurosci (2002) 1.83
Full genome screen for Alzheimer disease: stage II analysis. Am J Med Genet (2002) 1.77
Glycogen synthase kinase-3beta and tau genes interact in Alzheimer's disease. Ann Neurol (2008) 1.74
DAPK1 variants are associated with Alzheimer's disease and allele-specific expression. Hum Mol Genet (2006) 1.73
Proteome-based plasma markers of brain amyloid-β deposition in non-demented older individuals. J Alzheimers Dis (2010) 1.73
The C9ORF72 expansion mutation is a common cause of ALS+/-FTD in Europe and has a single founder. Eur J Hum Genet (2012) 1.71
SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer's disease. PLoS Genet (2010) 1.58
Glycogen synthase kinase-3 inhibition is integral to long-term potentiation. Eur J Neurosci (2007) 1.50
SORL1 variants and risk of late-onset Alzheimer's disease. Neurobiol Dis (2007) 1.49
Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. Hum Mol Genet (2012) 1.46
Multivariate analysis of MRI data for Alzheimer's disease, mild cognitive impairment and healthy controls. Neuroimage (2010) 1.44
The AddNeuroMed framework for multi-centre MRI assessment of Alzheimer's disease: experience from the first 24 months. Int J Geriatr Psychiatry (2011) 1.35
Automated hippocampal shape analysis predicts the onset of dementia in mild cognitive impairment. Neuroimage (2011) 1.34
Do antidepressants regulate how cortisol affects the brain? Psychoneuroendocrinology (2004) 1.32
Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment. Neuroimage (2011) 1.30
Candidate blood proteome markers of Alzheimer's disease onset and progression: a systematic review and replication study. J Alzheimers Dis (2014) 1.29
Deletion of Irs2 reduces amyloid deposition and rescues behavioural deficits in APP transgenic mice. Biochem Biophys Res Commun (2009) 1.28
MRI measures of Alzheimer's disease and the AddNeuroMed study. Ann N Y Acad Sci (2009) 1.28
Long-term cognitive and functional decline in late onset Alzheimer's disease: therapeutic implications. Age Ageing (2003) 1.26
Biomarkers for Alzheimer's disease therapeutic trials. Prog Neurobiol (2010) 1.26
Alpha-T-catenin is expressed in human brain and interacts with the Wnt signaling pathway but is not responsible for linkage to chromosome 10 in Alzheimer's disease. Neuromolecular Med (2004) 1.26
AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America. Neuroimage (2011) 1.24
Risk of developing dementia in people with diabetes and mild cognitive impairment. Br J Psychiatry (2010) 1.24
Inhibition of GSK-3 ameliorates Abeta pathology in an adult-onset Drosophila model of Alzheimer's disease. PLoS Genet (2010) 1.23
Genome screen for loci influencing age at onset and rate of decline in late onset Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet (2005) 1.22
Genome-wide linkage analysis of 723 affected relative pairs with late-onset Alzheimer's disease. Hum Mol Genet (2007) 1.16
Four components describe behavioral symptoms in 1,120 individuals with late-onset Alzheimer's disease. J Am Geriatr Soc (2006) 1.15
Effect of APOE ε4 allele on cortical thicknesses and volumes: the AddNeuroMed study. J Alzheimers Dis (2010) 1.12
Blood-based biomarkers of Alzheimer's disease: challenging but feasible. Biomark Med (2010) 1.12
Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease. Neurobiol Aging (2013) 1.12
Neurotoxic and neurotrophic roles of proNGF and the receptor sortilin in the adult and ageing nervous system. Eur J Neurosci (2008) 1.12
Mitochondrial dysfunction and immune activation are detectable in early Alzheimer's disease blood. J Alzheimers Dis (2012) 1.11
Proteome-based identification of plasma proteins associated with hippocampal metabolism in early Alzheimer's disease. J Neurol (2008) 1.11
Sensitivity and specificity of medial temporal lobe visual ratings and multivariate regional MRI classification in Alzheimer's disease. PLoS One (2011) 1.10
Combination analysis of neuropsychological tests and structural MRI measures in differentiating AD, MCI and control groups--the AddNeuroMed study. Neurobiol Aging (2009) 1.09
Association of ABCA1 with late-onset Alzheimer's disease is not observed in a case-control study. Neurosci Lett (2004) 1.09
Analysis of regional MRI volumes and thicknesses as predictors of conversion from mild cognitive impairment to Alzheimer's disease. Neurobiol Aging (2010) 1.08
p53 is upregulated in Alzheimer's disease and induces tau phosphorylation in HEK293a cells. Neurosci Lett (2007) 1.08
A comprehensive testing protocol for MRI neuroanatomical segmentation techniques: Evaluation of a novel lateral ventricle segmentation method. Neuroimage (2011) 1.06
Plasma biomarkers of brain atrophy in Alzheimer's disease. PLoS One (2011) 1.06
The importance of tau phosphorylation for neurodegenerative diseases. Front Neurol (2013) 1.05
A blood gene expression marker of early Alzheimer's disease. J Alzheimers Dis (2013) 1.05
Different multivariate techniques for automated classification of MRI data in Alzheimer's disease and mild cognitive impairment. Psychiatry Res (2013) 1.05
A feasibility and tolerability study of lithium in Alzheimer's disease. Int J Geriatr Psychiatry (2008) 1.04
Complement activation as a biomarker for Alzheimer's disease. Immunobiology (2011) 1.04
Glycogen synthase kinase-3 is increased in white cells early in Alzheimer's disease. Neurosci Lett (2005) 1.04
Evidence that common variation in NEDD9 is associated with susceptibility to late-onset Alzheimer's and Parkinson's disease. Hum Mol Genet (2007) 1.03
Alzheimer risk variant CLU and brain function during aging. Biol Psychiatry (2012) 1.02
The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease. J Alzheimers Dis (2012) 1.02
Identification of cis-regulatory variation influencing protein abundance levels in human plasma. Hum Mol Genet (2012) 1.02
The antidepressant clomipramine regulates cortisol intracellular concentrations and glucocorticoid receptor expression in fibroblasts and rat primary neurones. Neuropsychopharmacology (2003) 1.01
Entorhinal cortex thickness predicts cognitive decline in Alzheimer's disease. J Alzheimers Dis (2013) 1.01
APOE ε2 allele is associated with larger regional cortical thicknesses and volumes. Dement Geriatr Cogn Disord (2010) 1.00
Education increases reserve against Alzheimer's disease--evidence from structural MRI analysis. Neuroradiology (2012) 0.99
Over-expression of tau results in defective synaptic transmission in Drosophila neuromuscular junctions. Neurobiol Dis (2005) 0.99
Plasma transthyretin as a candidate marker for Alzheimer's disease. J Alzheimers Dis (2012) 0.99
Plasma based markers of [11C] PiB-PET brain amyloid burden. PLoS One (2012) 0.98
Magnetic resonance imaging and magnetic resonance spectroscopy for detection of early Alzheimer's disease. J Alzheimers Dis (2011) 0.98
GSK3alpha exhibits beta-catenin and tau directed kinase activities that are modulated by Wnt. Eur J Neurosci (2006) 0.97
Ubiquilin 1 polymorphisms are not associated with late-onset Alzheimer's disease. Ann Neurol (2006) 0.97
A proposed metabolic strategy for monitoring disease progression in Alzheimer's disease. Electrophoresis (2009) 0.96
Diagnosing Alzheimer's disease--non-clinicians and computerised algorithms together are as accurate as the best clinical practice. Int J Geriatr Psychiatry (2007) 0.94
Candidate gene association study of insulin signaling genes and Alzheimer's disease: evidence for SOS2, PCK1, and PPARgamma as susceptibility loci. Am J Med Genet B Neuropsychiatr Genet (2007) 0.93
Association studies between risk for late-onset Alzheimer's disease and variants in insulin degrading enzyme. Am J Med Genet B Neuropsychiatr Genet (2005) 0.92
OPCRIT+: an electronic system for psychiatric diagnosis and data collection in clinical and research settings. Br J Psychiatry (2011) 0.92
Plasma gelsolin is decreased and correlates with rate of decline in Alzheimer's disease. J Alzheimers Dis (2010) 0.92
Candidate gene association studies of genes involved in neuronal cholinergic transmission in Alzheimer's disease suggests choline acetyltransferase as a candidate deserving further study. Am J Med Genet B Neuropsychiatr Genet (2005) 0.92
Genetic variants influencing human aging from late-onset Alzheimer's disease (LOAD) genome-wide association studies (GWAS). Neurobiol Aging (2012) 0.92
TAp73 isoforms antagonize Notch signalling in SH-SY5Y neuroblastomas and in primary neurones. J Neurochem (2006) 0.91
Combinatorial markers of mild cognitive impairment conversion to Alzheimer's disease--cytokines and MRI measures together predict disease progression. J Alzheimers Dis (2011) 0.91
No evidence that extended tracts of homozygosity are associated with Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet (2011) 0.91
Sequence variation in the CHAT locus shows no association with late-onset Alzheimer's disease. Hum Genet (2003) 0.91
PTEN, a negative regulator of PI3 kinase signalling, alters tau phosphorylation in cells by mechanisms independent of GSK-3. FEBS Lett (2006) 0.91
Combining MRI and MRS to distinguish between Alzheimer's disease and healthy controls. J Alzheimers Dis (2010) 0.91
Genetic association of the APP binding protein 2 gene (APBB2) with late onset Alzheimer disease. Hum Mutat (2005) 0.90
Smell identification test as a treatment response marker in patients with Alzheimer disease receiving donepezil. J Clin Psychopharmacol (2009) 0.90
Positional pathway screen of wnt signaling genes in schizophrenia: association with DKK4. Biol Psychiatry (2007) 0.89
The NEO-FFI is a reliable measure of premorbid personality in patients with probable Alzheimer's disease. Int J Geriatr Psychiatry (2006) 0.89
Association of serotonin and dopamine gene pathways with behavioral subphenotypes in dementia. Neurobiol Aging (2010) 0.88
Plasma biomarkers for Alzheimer's disease: much needed but tough to find. Biomark Med (2012) 0.88
TAp73alpha induces tau phosphorylation in HEK293a cells via a transcription-dependent mechanism. Neurosci Lett (2006) 0.88
Truncated apoE forms tangle-like structures in a neuronal cell line. Neuroreport (2002) 0.88
Alzheimer's disease and age-related macular degeneration have different genetic models for complement gene variation. Neurobiol Aging (2012) 0.88
Nicastrin gene polymorphisms, cognitive ability level and cognitive ageing. Neurosci Lett (2005) 0.88
Wnt3a induces exosome secretion from primary cultured rat microglia. BMC Neurosci (2012) 0.87
Tocopherols and tocotrienols plasma levels are associated with cognitive impairment. Neurobiol Aging (2011) 0.87
Ageing increases vulnerability to aβ42 toxicity in Drosophila. PLoS One (2012) 0.87